NeuroDevNet — LLMpedia

NeuroDevNet
Name	NeuroDevNet
Formation	2009
Type	Research network
Headquarters	Vancouver, British Columbia
Leader title	Scientific Director
Leader name	Evdokia Anagnostou
Affiliations	Canadian Institutes of Health Research, SickKids, University of British Columbia

Contents

NeuroDevNet

NeuroDevNet was a Canadian research network focused on translating neuroscience discoveries into clinical practice for pediatric neurodevelopmental disorders. It brought together investigators from institutions such as the University of British Columbia, SickKids Hospital, McGill University, University of Toronto, and University of Alberta to address conditions like autism spectrum disorder, cerebral palsy, and Fetal Alcohol Spectrum Disorder. The network collaborated with national bodies including the Canadian Institutes of Health Research, provincial agencies such as BC Children’s Hospital, and international partners like Harvard Medical School and King's College London.

History

NeuroDevNet was launched in 2009 following a competitive grant from the Canadian Institutes of Health Research and the Networks of Centres of Excellence program, building on earlier consortia at institutions such as the Hospital for Sick Children and the University of Ottawa. Early collaborators included investigators affiliated with McMaster University, Queen's University, Dalhousie University, University of Calgary, and Simon Fraser University. Over time the network expanded to include research teams from Université de Montréal, Université Laval, University of Saskatchewan, Western University, and Memorial University of Newfoundland while engaging stakeholders from advocacy organizations like Autism Speaks and policy bodies such as the Canadian Paediatric Society.

NeuroDevNet’s mission emphasized accelerating translational research across domains represented by cores that mirrored priorities at institutions like Stanford University, Massachusetts General Hospital, and The Hospital for Sick Children. Its research focused on disorders including autism spectrum disorder, cerebral palsy, attention deficit hyperactivity disorder, Fragile X syndrome, Rett syndrome, and Fetal Alcohol Spectrum Disorder. The network integrated methodologies from centers such as Broad Institute, Cold Spring Harbor Laboratory, Salk Institute, and Max Planck Institute for Psychiatry to deploy genomics, imaging, and intervention trials. It fostered connections with clinical partners including BC Children’s Hospital, Alberta Children’s Hospital, The Ottawa Hospital, and Montreal Children’s Hospital.

NeuroDevNet operated via thematic teams and cores modeled on structures used by Wellcome Trust-funded consortia and multicenter groups like European Research Council projects. Leadership involved scientists from University of British Columbia, King's College London, McGill University Health Centre, and University of Toronto. Partnerships included provincial ministries such as British Columbia Ministry of Health, national funders including Canadian Institutes of Health Research, and international collaborators at institutions like Johns Hopkins University, Yale School of Medicine, UCL Great Ormond Street Institute of Child Health, and Karolinska Institutet. Knowledge translation activities connected to stakeholders like Children’s Hospital of Philadelphia, Mayo Clinic, Texas Children’s Hospital, and advocacy groups such as CanFASD and Autism Canada.

NeuroDevNet supported multicenter projects comparable to trials run at National Institutes of Health, European Molecular Biology Laboratory, and Australian National University. Initiatives included longitudinal cohort studies involving sites like BC Children’s Hospital Research Institute, The Hospital for Sick Children Research Institute, and Montreal Neurological Institute, biomarker discovery efforts collaborating with The Centre for Addiction and Mental Health, and early intervention trials modeled on programs from University of Melbourne and Karolinska Institutet. Training programs for clinician-scientists mirrored curricula at Harvard Medical School, University of Cambridge, and McMaster University. The network also developed data platforms influenced by standards from Human Brain Project, ENIGMA Consortium, and Genomics England.

Funding streams combined support from the Canadian Institutes of Health Research, provincial funding agencies like Ontario Ministry of Health and Alberta Innovates, philanthropic organizations such as The Lawson Foundation and J.W. McConnell Family Foundation, and partner hospitals including SickKids Foundation. Governance incorporated advisory boards with representation from entities like Health Canada, Public Health Agency of Canada, and international advisory members from National Institutes of Health and European Commission-funded programs. Scientific oversight drew on peer review models used by Wellcome Trust, Gordon and Betty Moore Foundation, and Bill & Melinda Gates Foundation.

NeuroDevNet contributed to translational pipelines similar to those at Toronto General Hospital Research Institute and produced outputs adopted by clinical centers such as BC Children’s Hospital, The Hospital for Sick Children, and Alberta Children’s Hospital. Its work influenced policy discussions at bodies like the Canadian Paediatric Society and informed practice guidelines used in provincial programs across British Columbia, Ontario, and Alberta. Collaborations led to publications and datasets integrated with consortia such as ENIGMA Consortium and informed training models at universities including University of British Columbia, McGill University, and University of Toronto. The network’s legacy includes capacity building reflected in ongoing programs at institutions like SickKids Research Institute, Montreal Neurological Institute, and BC Children’s Hospital Research Institute and continued partnerships with international centers such as Harvard Medical School, King’s College London, and Johns Hopkins University.

Category:Neuroscience organizations